Foghorn Therapeutics Inc. (FHTX) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -64.58M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-64.58M | (m) |
| 2026-03-31 | (m) | $-75.32M | (m) |
| 2025-12-31 | (m) | $-74.28M | (m) |
| 2025-09-30 | (m) | $-72.12M | (m) |
| 2025-06-30 | (m) | $-75.39M | (m) |
| 2025-03-31 | (m) | $-80.44M | (m) |
| 2024-12-31 | (m) | $-86.62M | (m) |
| 2024-09-30 | (m) | $-91.22M | (m) |
| 2024-06-30 | (m) | $-86.45M | (m) |
| 2024-03-31 | (m) | $-92.95M | (m) |
| 2023-12-31 | (m) | $-98.43M | (m) |
| 2023-09-30 | (m) | $-103.21M | (m) |
| 2023-06-30 | (m) | $-114.63M | (m) |
| 2023-03-31 | (m) | $-112.46M | (m) |
| 2022-12-31 | (m) | $-108.88M | (m) |
| 2022-09-30 | (m) | $-109.14M | (m) |
| 2022-06-30 | (m) | $-109.45M | (m) |
| 2022-03-31 | (m) | $-105.25M | (m) |
| 2021-12-31 | (m) | $-101.32M | (m) |
| 2021-09-30 | (m) | $-92.94M | (m) |
| 2021-06-30 | (m) | $-85.22M | (m) |
| 2021-03-31 | (m) | $-77.83M | (m) |
| 2020-12-31 | (m) | $-68.80M | (m) |
| 2020-09-30 | (m) | $-63.31M | (m) |
| 2020-06-30 | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) |
| 2019-12-31 | (m) | $-51.10M | (m) |
| 2019-09-30 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |